Portfolio News
Sofinnova Crossover & Sofinnova Industrial Biotech
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Related Company
SynthaceRelated Strategy
CrossoverRelated Strategy
Industrial BiotechRelated Deal lead
Joško BobanovićRelated News
Nitrase Therapeutics announces the appointment of three industry veterans to its Board of Directors
Mediar Therapeutics enters into a collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases
Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease
HAYA Therapeutics receives FDA Fast Track Designation for HTX-001
Moon Surgical and KARL STORZ Announce Strategic Commercial Collaboration to Advance Scalable Surgery